Application of "Heidelberg Triangle" Dissection in Pancreatoduodenectomy and Distal Pancreatectomy

Launched by FUDAN UNIVERSITY · Jan 26, 2023

Keywords

ClinConnect Summary

This clinical trial is studying a new surgical technique called "Heidelberg Triangle" dissection, which is being used alongside two types of surgery for pancreatic cancer: pancreatoduodenectomy and distal pancreatectomy. The goal of the trial is to see if this new approach improves safety and outcomes for patients with pancreatic cancer or cancers near the pancreas. The trial will look back at patients who had these surgeries between September 2016 and December 2022, comparing those who had the new dissection technique with those who did not.

To be eligible for this trial, patients should have been diagnosed with a type of pancreatic cancer that can be surgically removed and should be in good overall health, meaning they don’t have serious heart, lung, or blood issues. Participants can expect to be part of a study that monitors their recovery and health outcomes over time. It’s also important to note that pregnant or breastfeeding women, as well as those with other serious health conditions, cannot participate. The findings from this study could help improve surgical options for future patients facing similar diagnoses.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Patients diagnosed by preoperative imaging and auxiliary examination as resectable or borderline resectable pancreatic malignant tumor or periampullary carcinoma who underwent pancreatoduodenectomy or distal pancreatectomy, with or without TRIANGLE operation.
• • 2. Patients who have no serious abnormalities of blood system, heart and lung function and immune deficiency and can tolerate surgery.
• • 3. Be able to comply with the research visit plan and other program requirements
• Exclusion Criteria:
• • 1. Patients accompanied by other systemic malignancies.
• • 2. Central nervous system disease, mental disease, unstable angina pectoris, congestive heart failure, serious arrhythmia and other uncontrollable serious diseases, unable to tolerate surgery.
• • 3. Pregnant and lactating women.
• • 4. Any condition that may impair the safety of patients or the integrity of research data, including serious medical risk factors, medical conditions, and laboratory abnormalities.